Catalyst Capital Advisors LLC Amarin Corp Plcuk Transaction History

Catalyst Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$3.64 - $7.76 $956,956 - $2.04 Million	-262,900 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$4.78 - $8.26 $1.26 Million - $2.17 Million	262,900 New	262,900 $1.82 Million
Q1 2020 May 12, 2020	SELL	$4.0 - $21.53 $1.65 Million - $8.87 Million	-412,000 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$13.94 - $24.12 $1.78 Million - $3.09 Million	128,000 Added 45.07%	412,000 $8.83 Million
Q3 2019 Nov 05, 2019	BUY	$13.89 - $23.16 $708,390 - $1.18 Million	51,000 Added 21.89%	284,000 $4.31 Million
Q2 2019 Aug 08, 2019	SELL	$16.27 - $20.51 $195,240 - $246,120	-12,000 Reduced 4.9%	233,000 $4.52 Million
Q1 2019 May 08, 2019	BUY	$12.61 - $22.33 $665,808 - $1.18 Million	52,800 Added 27.47%	245,000 $5.09 Million
Q4 2018 Feb 07, 2019	BUY	$12.41 - $22.98 $2.39 Million - $4.42 Million	192,200 New	192,200 $2.62 Million

182

71.1M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $230M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.